Daily FNArena News

Last week local brokers spent a lot of time talking about China, while the banks, house prices and the local gold sector also featured.

Peter Kretzmer and Mickey Levy argue Greence may face an even more daunting task than did Argentina as the nation tries to implement needed economic reforms and return to fiscal sustainability.

Brokers discuss their views on Australian stock allocations with regard to the current climate of eurozone uncertainty.

Neuren Pharmaceuticals is making progress with its traumatic brain injury drug and Bell Potter reiterates a Buy rating.

A glance through the latest expert views and predictions about commodities with energy and iron ore sector recommendations updated, nickel’s weak outlook and steel market commentary.

A drop in HSBC’s flash estimate of China’s May PMI is not good news but may help hasten a policy response from Beijing.

This article follows up from out previous SMSF article on using options to enhance retiree returns, providing specific stock examples.

Brokers mostly see little in the way of respite for Myer’s sales weakness.

Fund manager Alphinity argues conditions are right for the next long up-cycle for insurance sector margins and share prices.

Jonathan Barratt of Barratt’s Bulletin looks to Beijing’s stimulus plans to halt the slide in the copper price.